Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device aims to make pancreatic and bile duct procedures safer

NCT ID NCT07696572

Recruiting now Disease control Sponsor: Orlando Health, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tracks up to 30 adults who need an endoscopic ultrasound (EUS) procedure using a new device called RIVOS. The device helps doctors access and treat problems like fluid collections, blockages, or chronic pancreatitis. Researchers will measure how often the procedure works and check for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RIVOS™ EUS access device
What this could lead to
If successful, this device could offer a safer, more effective way to drain fluid collections or relieve blockages in the pancreas and bile ducts without major surgery.
What could go wrong
This is a small, early registry study with only 30 patients, so results may not apply to everyone. There is a risk of procedure-related complications such as bleeding, infection, or device failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY OBSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholestasis chronic pancreatitis malignant pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILIARY OBSTRUCTION CHRONIC PANCREATITIS PANCREATIC CANCER NON-RESECTABLE PANCREATIC DUCT OBSTRUCTION PANCREATIC FLUID COLLECTIONS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Orlando Health Digestive Health Institute

    RECRUITING

    Orlando, Florida, 32806, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.